Skip to main content
Veterinary Medicines

Versifel FeLV,suspension for injection for cats

Authorised
  • Feline leukemia virus, strain Kawakami-Theilen, glycoprotein gp70

Product identification

Medicine name:
Versifel FeLV, suspension for injection
Versifel FeLV,suspension for injection for cats
Active substance:
  • Feline leukemia virus, strain Kawakami-Theilen, glycoprotein gp70
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline leukemia virus, strain Kawakami-Theilen, glycoprotein gp70
    8.10
    log2 geometric mean titre
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AA01
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • (ID2): 1 Box with 25 Bottle (Glass) with 1 Dose (25 Dose)
  • (ID1): 1 Box with 10 Bottle (Glass) with 1 Dose (10 Dose)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium SA
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10387/088/001
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0254/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Poland
  • Portugal
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 20/10/2023
Download

Summary of Product Characteristics

English (PDF)
Published on: 4/07/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."